Alan A. Wilson spends much of his time researching Internal medicine, Endocrinology, Dopamine, Neuroscience and Positron emission tomography. His Internal medicine study combines topics from a wide range of disciplines, such as Psychosis and Human brain. In Endocrinology, he works on issues like Serotonin transporter, which are connected to Serotonergic.
His studies in Dopamine integrate themes in fields like Catecholamine and Neurotransmitter. His work carried out in the field of Positron emission tomography brings together such families of science as Preclinical imaging, Stereochemistry, Imaging agent and Radioligand. His Receptor research includes elements of Pharmacology and Radiosynthesis.
Alan A. Wilson mainly focuses on Internal medicine, Endocrinology, Positron emission tomography, Pharmacology and Receptor. His Internal medicine research focuses on Prefrontal cortex and how it connects with Monoamine oxidase A. His Endocrinology study integrates concerns from other disciplines, such as Agonist and Neuroscience.
His biological study spans a wide range of topics, including Biodistribution, Human brain and Nuclear magnetic resonance. Alan A. Wilson combines subjects such as Risperidone, Ex vivo, Olanzapine and Antipsychotic with his study of Pharmacology. His research in Receptor focuses on subjects like Stereochemistry, which are connected to Radiosynthesis, Chemical synthesis and In vitro.
Alan A. Wilson mostly deals with Internal medicine, Endocrinology, Positron emission tomography, Dopamine and Prefrontal cortex. His study in Internal medicine is interdisciplinary in nature, drawing from both Major depressive disorder, Anterior cingulate cortex and Major depressive episode. He has included themes like Endocannabinoid system and Human brain in his Endocrinology study.
His work carried out in the field of Positron emission tomography brings together such families of science as Radiochemistry, Asymptomatic and Neuroimaging. The concepts of his Dopamine study are interwoven with issues in Agonist, Schizophrenia and Pharmacology. He has included themes like Serotonin transporter, DASB and Serotonin in his Neuroscience study.
Alan A. Wilson mainly investigates Internal medicine, Endocrinology, Translocator protein, Positron emission tomography and Anterior cingulate cortex. Many of his studies involve connections with topics such as Major depressive episode and Internal medicine. His study in Endocrinology is interdisciplinary in nature, drawing from both Parkinson's disease and Endocannabinoid system.
His Translocator protein study combines topics in areas such as Neuroscience, Putamen and Radioligand. His Positron emission tomography study integrates concerns from other disciplines, such as Biochemistry, Carboxylic acid, Enzyme, Methyl iodide and Genetic variants. The various areas that Alan A. Wilson examines in his Ventral striatum study include Agonist and Dopamine receptor D2, Dopamine receptor D3.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics
Dean F. Wong;Henry N. Wagner;Larry E. Tune;Robert F. Dannals.
Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain
D F Wong;H N Wagner;R F Dannals;J M Links.
Neuroanatomical correlates of encoding in episodic memory: levels of processing effect
Shitij Kapur;Fergus I. M. Craik;Endel Tulving;Alan A. Wilson.
Proceedings of the National Academy of Sciences of the United States of America (1994)
Elevated Monoamine Oxidase A Levels in the Brain: An Explanation for the Monoamine Imbalance of Major Depression
Jeffrey H. Meyer;Nathalie Ginovart;Anahita Boovariwala;Sandra Sagrati.
Archives of General Psychiatry (2006)
Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Elaine Setiawan;Alan A. Wilson;Alan A. Wilson;Romina Mizrahi;Pablo M. Rusjan.
JAMA Psychiatry (2015)
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Jeffrey H. Meyer;Alan A. Wilson;Sandra Sagrati;Doug Hussey.
American Journal of Psychiatry (2004)
5-HT2 and D2 Receptor Occupancy of Olanzapine in Schizophrenia: A PET Investigation
Shitij Kapur;Robert B. Zipursky;Gary Remington;Corey Jones.
American Journal of Psychiatry (1998)
In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.
Nicolaas P L G Verhoeff;Alan A Wilson;Shinichiro Takeshita;Liat Trop.
American Journal of Geriatric Psychiatry (2004)
Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.
Jeffrey H. Meyer;Alan A. Wilson;Nathalie Ginovart;Verdell Goulding.
American Journal of Psychiatry (2001)
PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression.
Mayberg Hs;Robinson Rg;Wong Df;Parikh R.
American Journal of Psychiatry (1988)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: